You are here: Industry Insights > CDSCO

News List

CDSCO approves study on mixing of Covaxin and Covishield doses expresspharma
August 13, 2021
"The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the inoculation course," a source said.
Zydus Cadila gets CDSCO nod for clinical trials of antibodies cocktail to treat COVID-19: Sources expresspharma
June 07, 2021
Zydus Cadila has been given permission to conduct clinical trials on neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) ...
SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds expresspharma
May 13, 2021
The trial will be conducted on 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
States must ensure special teams to prevent black marketing of drugs: Centre to SC expresspharma
May 11, 2021
All states must ensure special teams at different levels to “mercilessly clamp down” on hoarding and black marketing of drugs during the COVID-19 pandemic and send a clear message that “trading in human miseries” shall not be tolerated, the Centre has ...
MoHF&W issues guidelines for COVID-19 vaccine import by private sector expresspharma
May 07, 2021
MoHF&W has said that the ready-to-use imported COVID vaccine would be allowed to be utilised entirely in the other-than- Government of India channel.”
NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19 expresspharma
April 27, 2021
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2 replication.
Mankind Pharma seeks CDSCO approval for Phase 1 Clinical Trials of patented anti-diabetic molecule expresspharma
April 16, 2021
Mankind Pharma has submitted its first Investigational New Drug (IND) application for approval to Central Drugs Standard Control Organisation (CDSCO) for MKP10241, a patented novel anti-diabetic molecule.
SEC of CDSCO recommends approval to Sputnik V for EUA in India expresspharma
April 13, 2021
The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
J&J in discussions with Indian regulator to begin trial of single-dose vaccine expresspharma
April 12, 2021
India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme.
CDSCO’s expert panel recommends approval for phase 1 trial of Bharat Biotech’s nasal vaccine for COVID-19 expresspharma
January 21, 2021
An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes.

Previous page 1 2 3 4 Next page